Lugui R. Qiu

Tianjin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Journal: Leukemia
Published: June 09, 2026

Advances in the treatment and genetics and translational research of patients with Mantle cell lymphoma

Advances in the treatment and genetics and translational research of patients with Mantle cell lymphoma

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: March 11, 2026

Acalabrutinib vs chlorambucil plus rituximab in untreated chronic lymphocytic leukemia: A randomized phase 3 Asian study.

Acalabrutinib vs chlorambucil plus rituximab in untreated chronic lymphocytic leukemia: A randomized phase 3 Asian study.

Journal: Annals of hematology
Published: October 16, 2025

An exploratory study on new indicators of AVS in the typing diagnosis of primary aldosteronism

An exploratory study on new indicators of AVS in the typing diagnosis of primary aldosteronism

Journal: Zhonghua xin xue guan bing za zhi
Published: September 15, 2025

Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study.

Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study.

Journal: MedScience
Published: August 06, 2025

Development and validation of a prognostic staging system for primary plasma cell leukemia.

Development and validation of a prognostic staging system for primary plasma cell leukemia.

Journal: Journal of hematology & oncology
Published: April 30, 2025

Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report.

Uncommon biphasic CAR-T expansion induces hemophagocytic lymphohistiocytosis-like syndrome and fatal multiple infections following BCMA CAR-T cell therapy: a case report.

Journal: Journal for immunotherapy of cancer
Published: November 08, 2024

The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma.

The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma.

Journal: Annals of hematology
Published: October 28, 2024

Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.

Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.

Journal: Signal transduction and targeted therapy
Published: August 28, 2024

Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma.

Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma.

Journal: Leukemia
Published: May 26, 2024

The Optimal Storage Condition and Storage Time of Umbilical Cord Blood from Collection to Preparation

The Optimal Storage Condition and Storage Time of Umbilical Cord Blood from Collection to Preparation

Journal: Zhongguo shi yan xue ye xue za zhi
Published: April 25, 2024

Lymphoma cell-driven IL-16 is expressed in activated B-cell-like diffuse large B-cell lymphomas and regulates the pro-tumor microenvironment.

Lymphoma cell-driven IL-16 is expressed in activated B-cell-like diffuse large B-cell lymphomas and regulates the pro-tumor microenvironment.

Journal: Haematologica
Published: February 26, 2024
Showing 1-12 of 93

Last Updated: 09/26/2026